HLA-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the TNF-alpha-308 G/A polymorphism
Makela, S.; Mustonen, J.; Ala Houhala, I.; Hurme, M.; Partanen, J.; Vapalahti, O.; Vaheri, A.; Pasternack, A.
Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 61
2002
ISSN/ISBN: 0931-0509 Accession: 035011710
Full Text Article emailed within 1 workday: $29.90
Related References
Mäkelä, S.; Mustonen, J.; Ala-Houhala, I.; Hurme, M.; Partanen, J.; Vapalahti, O.; Vaheri, A.; Pasternack, A. 2002: Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism Journal of Infectious Diseases 186(6): 843-846Makela, S.; Mustonen, J.; Alahouhala, I.; Hurme, M.; Partanen, J.; Vapalahti, O.; Vaheri, A.; Pasternack, A. 2002: Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-α(-308) G/A polymorphism The Journal of Infectious Diseases 186(6): 843-846
Mäkelä, S.; Hurme, M.; Ala-Houhala, I.; Mustonen, J.; Koivisto, A.M.; Partanen, J.; Vapalahti, O.; Vaheri, A.; Pasternack, A. 2001: Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 16(7): 1368-1373
Mcrose, A.; Vapalahti, O.; Lyytikainen, O.; Nuorti, P. 2003: Les infections à hantavirus Puumala en Finlande - Patterns of Puumala virus infection in Finland Euro Surveillance 8(1): 9-13
Koskela, S.; Laine, O.; Mäkelä, S.; Pessi, T.; Tuomisto, S.; Huhtala, H.; Karhunen, P.J.; Pörsti, I.; Mustonen, J. 2015: Endothelial Nitric Oxide Synthase G894T Polymorphism Associates with Disease Severity in Puumala Hantavirus Infection Plos one 10(11): E0142872
Thomas, C.; Fourrier, F.; Guilbaut, J.C.; Le Guenno, B.; Chopin, C. 1997: Puumala type hantavirus infection with early choleriform syndrome and severe multiorgan failure Intensive Care Medicine 23(6): 708-709
Antonen, J.; Leppänen, I.; Tenhunen, J.; Arvola, P.; Mäkelä, S.; Vaheri, A.; Mustonen, J. 2013: A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant Scandinavian Journal of Infectious Diseases 45(6): 494-496
Mantula, P.S.; Outinen, T.K.; Jaatinen, P.; Hämäläinen, M.; Huhtala, H.; Pörsti, I.H.; Vaheri, A.; Mustonen, J.T.; Mäkelä, S.M. 2018: High plasma resistin associates with severe acute kidney injury in Puumala hantavirus infection Plos one 13(12): E0208017
Vaheri, A.; Strandin, T.; Jääskeläinen, A.J.; Vapalahti, O.; Jarva, H.; Lokki, M.-L.; Antonen, J.; Leppänen, I.; Mäkelä, S.; Meri, S.; Mustonen, J. 2014: Pathophysiology of a severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant Antiviral Research 111: 23-25
Eckerle, I.; Jakob, E.; Hofmann, J.; Schmidt-Bacher, A.; Ettinger, J.; Schnitzler, P. 2012: Atypical severe Puumala hantavirus infection and virus sequence analysis of the patient and regional reservoir host Zoonoses and Public Health 59(Suppl 2): 110-115
Latus, J.; Tenner-Racz, K.; Racz, P.; Kitterer, D.; Cadar, D.; Ott, G.; Alscher, M.D.; Schmidt-Chanasit, J.; Braun, N. 2014: Detection of Puumala hantavirus antigen in human intestine during acute hantavirus infection Plos one 9(5): E98397
Latronico, F.; Mäki, S.; Rissanen, H.; Ollgren, J.; Lyytikäinen, O.; Vapalahti, O.; Sane, J. 2018: Population-based seroprevalence of Puumala hantavirus in Finland: smoking as a risk factor Epidemiology and Infection 146(3): 367-371
Klingström, J.; Smed-Sörensen, A.; Maleki, K.T.; Solà-Riera, C.; Ahlm, C.; Björkström, N.K.; Ljunggren, H.G. 2019: Innate and adaptive immune responses against human Puumala virus infection: immunopathogenesis and suggestions for novel treatment strategies for severe hantavirus-associated syndromes Journal of Internal Medicine 285(5): 510-523
Bergstedt Oscarsson, K.; Brorstad, A.; Baudin, M.; Lindberg, A.; Forssén, A.; Evander, M.; Eriksson, M.; Ahlm, C. 2016: Human Puumala hantavirus infection in northern Sweden; increased seroprevalence and association to risk and health factors Bmc Infectious Diseases 16(1): 566
Hautala, T.; Hautala, N.; Mähönen, S-Mari.; Sironen, T.; Pääkkö, E.; Karttunen, A.; Salmela, P.I.; Vainio, O.; Rytky, S.; Plyusnin, A.; Vaheri, A.; Vapalahti, O.; Kauma, H. 2011: Young male patients are at elevated risk of developing serious central nervous system complications during acute Puumala hantavirus infection Bmc Infectious Diseases 11: 217
Goeijenbier, M.; Meijers, J.C.M.; Anfasa, F.; Roose, J.M.; van de Weg, C.A.M.; Bakhtiari, K.; Henttonen, H.; Vaheri, A.; Osterhaus, A.D.M.E.; van Gorp, E.C.M.; Martina, B.E.E. 2015: Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release Frontiers in Microbiology 6: 220
Rohfritsch, A.; Guivier, E.; Galan, M.; Chaval, Y.; Cosson, J.F.; Charbonnel, N. 2013: Apport de l'immunogénétique À la Compréhension des Interactions entre le Campagnol Roussâtre Myodes Glareolus et l'hantavirus Puumala - Insights into Myodes Glareolus / Puumala Hantavirus Interactions from Rodent Immunogenetics Bulletin de l'Academie Veterinaire de France 166(2): 171-183
Koskela, S.; Mäkelä, S.; Strandin, T.; Vaheri, A.; Outinen, T.; Joutsi-Korhonen, L.; Pörsti, I.; Mustonen, J.; Laine, O. 2021: Coagulopathy in Acute Puumala Hantavirus Infection Viruses 13(8)
Mustonen, J.; Outinen, T.; Laine, O.; Pörsti, I.; Vaheri, A.; Mäkelä, S. 2017: Kidney disease in Puumala hantavirus infection Infectious Diseases 49(5): 321-332
Sironen, T.; Klingström, J.; Vaheri, A.; Andersson, L.C.; Lundkvist, A.; Plyusnin, A. 2008: Pathology of Puumala hantavirus infection in macaques Plos one 3(8): E3035